CDC Updates

  • COVID-19 boosters for all eligible individuals age 12+ who have completed their primary vaccine series.
  • Individuals who received the Pfizer-BioNTech COVID-19 Vaccine as their primary series to get a booster after 5 instead of 6 months.
  • Moderately or severely immunocompromised 5–11-year-olds to receive an additional primary dose of the Pfizer-BioNTech COVID-19 vaccine 28 days after their second shot.
  • Individuals should receive an mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna) over Johnson and Johnson’s COVID-19 vaccine.

Ahora ofrecemos la vacuna COVID-19 gratis*.
¡Las personas sin cita son bienvenidas!

Las farmacias de Fresco y Más ahora pueden administrar la vacuna COVID-19. Nuestros farmacéuticos tienen experiencia en proporcionar vacunas de forma segura, como la gripe, el herpes zóster y la neumonía. Como siempre, seguimos todas las pautas recomendadas por los CDC y el estado. Programe su cita para ahorrar tiempo. ¡Las visitas sin cita son siempre bienvenidas! Para ahorrar tiempo, descargue nuestro formulario de consentimiento ahora.

  • *Sin costo a través de la mayoría de los seguros o de un programa federal si no está asegurado. La disponibilidad puede cambiar rápidamente según la demanda; entendemos que esto puede resultar frustrante. Si no hay citas disponibles en la ubicación que seleccionó, puede elegir una ubicación cercana o consultar con frecuencia para la próxima oportunidad de programar su cita.

COVID Vaccines and Doses

Vaccine Doses Eligibility/ Approval Information
Moderna mRNA
  • First Dose
  • Second Dose (28 days after first)
  • Third Dose (For moderately to severely immunocompromised: 28 days after second dose)
  • Booster dose (5 months after second dose)
  • Ages 18+
FDA Vaccine Overview
Pfizer-BioNTech
mRNA
  • First Dose
  • Second Dose (21 days after first dose)
  • Third Dose (For moderately to severely immunocompromised: 28 days after second dose)
  • Ages 5 to 11
CDC Vaccine Overview
(Ages 5-11)
  • First Dose
  • Second Dose (21 days after first dose)
  • Third Dose (For moderately to severely immunocompromised: 28 days after second dose)
  • Booster dose (5 months after second dose)
  • Ages 12+
CDC Vaccine Overview

CDC Booster Overview
Johnson & Johnson (Janssen)
  • Single Dose
  • Booster Dose (2 months after first dose)
  • Ages 18+
CDC Vaccine Overview

CDC Booster Overview

Promote health and wellness in your community or workplace

We're here to support your organization's on‐site clinic needs. We would be happy to conduct an on‐site vaccine clinic for your organization or community.

Clinic facts and requirements

Ready to request an off-site vaccine clinic for your business or organization?

COVID-19 vaccine FAQs

    The CDC is expressing a clinical preference for individuals to receive an mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna) over Johnson & Johnson’s COVID-19 vaccine. This recommendation followed a robust discussion of the latest evidence on vaccine effectiveness, vaccine safety and rare adverse events, and consideration of the U.S. vaccine supply.

    However, ACIP reaffirmed that receiving any vaccine is better than being unvaccinated. Individuals who are unable or unwilling to receive an mRNA vaccine will continue to have access to Johnson & Johnson’s COVID-19 vaccine.


    Individuals age 12+ are eligible to receive the Pfizer-BioNTech COVID-19 vaccine booster if they completed the Pfizer-BioNTech vaccine series 5 months ago.

    Adults 18 years and older can get any of the COVID-19 vaccine boosters authorized in the United States as long as they completed the Pfizer-BioNTech 5 months ago, Moderna vaccine series 6 months ago or received the single dose Johnson & Johnson vaccine 2 months ago.


    Individuals age 12+ are eligible to receive the Pfizer-BioNTech COVID-19 vaccine booster if they completed the Pfizer-BioNTech vaccine series 5 months ago.

    If you are 18 and older, you may choose any of the three available COVID-19 vaccines in the United States as a booster shot. Some people may prefer the vaccine type that they originally received, and others may prefer to get a different booster. CDC’s recommendations now allow for this type of mix and match dosing for booster shots.
    Learn more


    With many children back in school and participating in extracurricular activities, COVID-19 vaccination among children ages 5 through 11 years is critical to preventing infection and possible severe disease, as well as reducing the spread of COVID-19. There are approximately 28 million children between the ages of 5 and 11 in the United States, and there have been nearly 2 million cases of COVID-19 within this age group during the pandemic. While fewer children have been sick with COVID-19 compared to adults, children can be infected with the virus, and there is no way to tell in advance if a child will get a severe or mild case. Some children have developed a rare but serious disease that is linked to COVID-19 called multisystem inflammatory syndrome (MIS-C).


    Based on data from the clinical trial, children may have some side effects from COVID-19 vaccination, which are normal signs that their body is building protection. These side effects may affect your child’s ability to do daily activities, but they should go away in a few days. Serious side effects are rare but may occur.


    Select Fresco Y Más Pharmacy locations will be offering the Pfizer-BioNTech COVID-19 vaccine for ages 5 to 11. Click here to view our store list.


    As opposed to many medications, vaccine dosages are based on age and not size or weight. If a child turns from 11 to 12 years of age in between their first and second dose, they should receive the age- appropriate dose at the time of administration.


    The Pfizer-BioNTech Vaccine for children ages 5 through 11 has the same active ingredients as the vaccine given to adults and adolescents. The Pfizer-BioNTech Vaccine that is given to adults and adolescents cannot be used for children ages 5 through 11 years. Children ages 5 through 11 will receive an age-appropriate dose that is one third of what adolescents and adults receive. Smaller needles, designed specifically for children, are used for children ages 5 through 11 years. COVID-19 vaccine dosage does not vary by patient weight but by age on the day of vaccination. Children are still required to get two doses three weeks apart to be considered fully vaccinated.


    No. There is no evidence that any vaccines, including COVID-19 vaccines, can cause female or male fertility problems.


    Yes, if a patient is eligible, both flu and COVID-19 vaccines can be administered at the same visit, as recommended by CDC and ACIP. In addition to flu vaccine, COVID-19 vaccine can be given with other vaccines as well.


    Yes, COVID-19 vaccines are available for everyone at no cost, including the Pfizer-BioNTech Vaccine for children ages 5 through 11 years. COVID-19 vaccines will continue to be given to all eligible people living in the United States, regardless of insurance or immigration status.


    Yes, all vaccine recipients, including children ages 5 through 11 years, will receive a CDC vaccination card upon initial vaccination.


    Certain individuals who are moderately to severely immunocompromised may not build enough (or any) protection when they first get a vaccination. When this happens, getting another dose of the vaccine can sometimes help them build more protection against the disease. CDC recommends moderately to severely immunocompromised people consider receiving an additional (third) dose of an mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna) at least 28 days after the completion of the initial 2-dose mRNA COVID-19 vaccine series.

    In contrast, a “booster dose” refers to another dose of a vaccine that is given to someone who built enough protection after vaccination, but then that protection decreased over time (this is called waning immunity).


    For many who have completed their primary series with Pfizer-BioNTech vaccine, the benefits of getting a booster shot outweigh the known and potential risks. So far, reactions reported after the third PfizerBioNTech shot were similar to that of the 2-shot primary series. Fatigue and pain at the injection site were the most commonly reported side effects, and overall, most side effects were mild to moderate. However, as with the 2-shot primary series, serious side effects are rare, but may occur.


    You can walk-in or schedule an appointment for your second dose Moderna or Pfizer vaccine even if you received your first dose Moderna or Pfizer vaccine at a different location.


    Customers can earn $10 in free groceries with each COVID-19 vaccine. Click here for details.


    As of August 23, 2021, the FDA has issued full approval of the Pfizer-BioNTech vaccine for ages 16+. The FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness and quality of COVID-19 vaccines. Other COVID-19 vaccines are in development and will be reviewed by the FDA under EUA. Find the current status of the vaccine approvals and EUAs.


    Yes, the additional dose is available at no cost to any eligible patient either through insurance or a federal program for the uninsured.


    Please visit the CDC's page on variants for more information.


    Fresco y Más will be administering the Pfizer and Moderna vaccine. The type of vaccine will vary by state. Click to learn more about each vaccine, the Moderna Vaccine Fact Sheet and Pfizer Vaccine Fact Sheet.


    The U.S. vaccine safety system ensures that all vaccines are as safe as possible. Safety is a top priority while federal partners work to make this and other COVID-19 vaccines available.

    https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety.html


    The CDC and FDA encourage the public to report possible side effects (called adverse events) to the Vaccine Adverse Event Reporting System (VAERS). This national system collects these data to look for adverse events that are unexpected, appear to happen more often than expected, or have unusual patterns of occurrence. Learn about the difference between a vaccine side effect and an adverse event. Reports to VAERS help the CDC monitor the safety of vaccines. Safety is a top priority. Healthcare providers will be required to report certain adverse events following vaccination to VAERS. Healthcare providers also have to adhere to any revised safety reporting requirements according to FDA’s conditions of authorized use throughout the duration of any Emergency Use Authorization; these requirements would be posted on FDA’s website.

    The CDC is also implementing a new smartphone-based tool called v-safe to check-in on people’s health after they receive a COVID-19 vaccine. When you receive your vaccine, you should also receive a v-safe information sheet telling you how to enroll in v-safe. If you enroll, you will receive regular text messages directing you to surveys where you can report any problems or adverse reactions you have after receiving a COVID-19 vaccine.

    V-Safe information sheet
    V-Safe information poster


    COVID-19 vaccines help our bodies develop immunity to the virus that causes COVID-19 without us having to get the illness. Different types of vaccines work in different ways to offer protection, but with all types of vaccines, the body is left with a supply of “memory” T-lymphocytes as well as B-lymphocytes that will remember how to fight that virus in the future. It typically takes a few weeks for the body to produce T-lymphocytes and B-lymphocytes after vaccination. Therefore, it is possible that a person could be infected with the virus that causes COVID-19 just before or just after vaccination and then get sick because the vaccine did not have enough time to provide protection. Sometimes after vaccination, the process of building immunity can cause symptoms, such as fever. These symptoms are normal and are a sign that the body is building immunity.

    https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fvaccines%2Fabout-vaccines%2Fhow-they-work.html


    Vaccine doses will be given to the American people at no cost. The Federal Bureau of Investigation (FBI), Department of Health and Human Services Office of Inspector General (HHS-OIG), and Centers for Medicare & Medicaid Services (CMS) are warning the public about several emerging fraud schemes related to COVID-19 vaccines. If you believe you have been the victim of a COVID-19 fraud, immediately report it to the FBI (ic3.gov, tips.fbi.gov, or 1-800-CALL-FBI) or HHS OIG (tips.hhs.gov or 1-800-HHS-TIPS)


Encuentre su farmacia más cercana.

¿Busca una tienda cerca de usted? Encuentre una farmacia Fresco y Más en su área

One moment, please